Clinical electrophysiologic effects of a single high oral dose of amiodarone

Fundamental and Clinical Pharmacology

Volumn 11, Issue 3, 1997, Pages 275-280

  Deharo, J C ^a   Durand, A ^b   Macaluso, G ^a   Malaterre, H ^a   Le Tallec, L ^a   Panagides, D ^b   Bory, M ^b   Djiane, P ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b TIMONE HOSPITAL   (France)

Author keywords

Electrophysiologic effects; Electrophysiologic study; Oral amiodarone

Indexed keywords

AMIODARONE; DEETHYLAMIODARONE;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; FEMALE; HEART ARRHYTHMIA; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QT INTERVAL;

EID: 0030986857     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00196.x     Document Type: Article

References (24)

1. Coutte R, Fontaine G, Franck R, Dragodanne C, Phan-Tuc H, Facquet J. Etude électrocardiologique des effets de l'amiodarone sur la conduction intracardiaque chez l'homme. Ann Cardiol Angeiol 1976;6:543-8
2. Djiane P, Arnoux Ph, Lambert C et al. Plasma, red blood cells and myocardial concentrations of amiodarone and desethylamiodarone following IV administration in humans. J Electrophysiol 1987;1:274-8
3. Escoubet B, Poirier JM, Maison-Blanche P et al. Effet antiarythmique de l'amiodarone dans les 24 heures suivant une dose de charge orale unique. Arch Mal Cœur 1985a;78: 1046-52
4. Escoubet B, Coumel Ph, Poirier JM et al. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations. Am J Cardiol 1985b;55:696-702
5. Escoubet B, Jaillon P, Berger Y et al. Amiodarone and N-desethylamiodarone concentrations in plasma, red blood cells, and myocardium after a single oral dose: relation to hemodynamic effects in surgical patients. Am Heart J 1986;111:280-5
6. Finermann WB, Hamer A, Peter T, Weiss D, Mandel WJ. Electrophysiologic effects of chronic amiodarone therapy in patients with ventricular arrhythmias. Am Heart J 1982; 104:987-96
7. Gloor HO, Urthaler F, James TN. Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region. J Clin Invest 1983;71:1457-66
8. Gomes JA, Kang PS, Hariman RJ, El Sherif N, Lyons J. Electrophysiologic effects and mechanisms of termination of supraventricular tachycardia by intravenous amiodarone. Am Heart J 1984;107:214-21
9. Goupil N, Lenfant J. The effects of amiodarone on the sinus node activity of the rabbit heart. Eur J Pharmacol 1976;39: 23-31
10. Haffajee CI, Love JC, Alpert JS, Asdourian GK, Sloan KC. Efficacy and safety of long-term amiodarone in the treatment of cardiac arrhythmias: dosage experience. Am Heart J 1983;106:935-43
11. Kannan R, Nademanee K, Hendrickson JA, Rostami HJ, Singh BN. Amiodarone kinetics after oral doses. Clin Pharmacol Ther 1982;31:438-44
12. Kates RE, Kannan R, Singh BN. Pharmacokinetics of class III antiarrhythmic agents. In: Singh BN, ed. Control of cardiac arrhythmias by lengthening repolarization. Mount Kisko: Futura Publishing Company, 1988;175-207
13. Mason JW, Hondeghem LM, Katzung BG. Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res 1984;55:277-85
14. Nademanee K, Hendrickson JA, Kannan R, Singh BN. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occuring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia. Am Heart J 1982;103:950-9
15. Rakita L, Mostow ND. Side effect profile of amiodarone and approaches to optimal dosing. In: Singh BN, ed. Control of cardiac arrhythmias by lengthening repolorization. Mount Kisko: Futura Publishing Company, 1988;509-41
16. Rakita L, Sobol SM. Amiodarone in the treatment of refractory ventricular arrhythmias - Importance and safety of initial high-dose therapy. JAMA 1983;250:1293-5
17. Saksena S, Rothbart ST. Comparative pharmaco-electrophysiology of intravenous and oral amiodarone in refractory ventricular tachycardia. Clin Res 1983;31:254 A
18. Siddoway LA, McAllister B, Wilkinson GR, Roden DM, Woosley RL. Amiodarone dosing: A proposal based on its pharmacokinetics. Am Heart J 1983;106:951-6
19. Singh BN. Amiodarone: historical development and pharmacologie profile. Am Heart J 1983;106:788-97
20. Singh BN. Comparative mechanism of action of different antiarrhythmic agents: significance of lengthening of repolarization. In: Singh BN, ed. Control of cardiac arrhythmias by lengthening repolarization. Mount Kisko: Futura Publishing Company, 1988;53-127
21. Touboul P, Atallah G, Gressard A, Kirkorian G. Effects of amiodarone on sinus node in man. Br Heart J 1979;42:573-8
22. Touboul P, Huerta F, Porte J. Delahaye JP. Bases électrophysiologiques de l'action antiarythmique de l'amiodarone chez l'homme. Arch Mal Cœur 1976;69:845-53
23. Ward DE, Camm AJ. Clinical electrophysiological methods. In: Ward DE, Camm AJ, eds. Clinical electrophysiology of the heart. Baltimore: Edward Arnold, 1987;21-3
24. Wellens HJ, Brugada P, Abdollah H, Dassen WR. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient. Circulation 1984;69:120-4